Methylene blue for vasoplegic syndrome treatment in heart surgery. Fifteen years of questions, answers, doubts and certainties

Objective: There is strong evidence that methylene blue (MB), an inhibitor of guanylate cyclase, is an excellent therapeutic option for vasoplegic syndrome (VS) treatment in heart surgery. The aim of this article is to review the MB’s therapeutic function in the vasoplegic syndrome treatment. Metho...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Revista Brasileira de Cirurgia Cardiovascular/Brazilian Journal of Cardiovascular Surgery
Κύριοι συγγραφείς: Paulo Roberto Barbosa EVORA, Paulo José de Freitas RIBEIRO, Walter Vilella de Andrade VICENTE, Celso Luís dos REIS, Alfredo José RODRIGUES, Antonio Carlos MENARDI, Lafaiete ALVES JUNIOR, Patrícia Martinez EVORA, Solange BASSETTO
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Sociedade Brasileira de Cirurgia Cardiovascular 2009
Θέματα:
Medicina
drug effects
Methylene blue
Vascular diseases
Vascular resistance
Extracorporeal circulation
Διαθέσιμο Online:https://www.redalyc.org/articulo.oa?id=398941872005
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια